SFM
SNDX icon

Sphera Funds Management’s Syndax Pharmaceuticals SNDX Stock Holding History

Quarter Market Value Status Shares Shares
Change %
Trade Value Portfolio Weight Portfolio Position
2025
Q2
$14.7M Sell
1,571,564
-92,410
-6% -$865K 3.45% 3
2025
Q1
$20.4M Buy
1,663,974
+282,733
+20% +$3.47M 4.71% 2
2024
Q4
$18.3M Buy
1,381,241
+346,395
+33% +$4.58M 3.3% 4
2024
Q3
$19.9M Buy
1,034,846
+212,799
+26% +$4.1M 3.17% 4
2024
Q2
$16.9M Buy
822,047
+9,083
+1% +$186K 2.3% 5
2024
Q1
$19.3M Buy
812,964
+40,000
+5% +$952K 2.72% 5
2023
Q4
$16.7M Sell
772,964
-97
-0% -$2.1K 2.69% 5
2023
Q3
$11.2M Buy
773,061
+50,000
+7% +$726K 2.04% 8
2023
Q2
$15.1M Buy
723,061
+40,000
+6% +$837K 2.36% 6
2023
Q1
$14.4M Sell
683,061
-27,500
-4% -$581K 2.41% 7
2022
Q4
$18.1M Sell
710,561
-112,135
-14% -$2.85M 3.88% 4
2022
Q3
$19.8M Sell
822,696
-316,633
-28% -$7.61M 2.74% 8
2022
Q2
$21.9M Sell
1,139,329
-138,084
-11% -$2.66M 2.34% 9
2022
Q1
$22.2M Buy
1,277,413
+100,828
+9% +$1.75M 3.14% 9
2021
Q4
$25.8M Buy
1,176,585
+425,982
+57% +$9.32M 2.83% 7
2021
Q3
$14.3M Buy
750,603
+203,416
+37% +$3.89M 1.21% 15
2021
Q2
$9.4M Sell
547,187
-90,906
-14% -$1.56M 0.64% 34
2021
Q1
$14.3M Sell
638,093
-107,807
-14% -$2.41M 1.09% 12
2020
Q4
$16.6M Buy
745,900
+235,900
+46% +$5.25M 1.47% 12
2020
Q3
$7.53M Buy
510,000
+290,000
+132% +$4.28M 0.74% 33
2020
Q2
$3.26M Buy
220,000
+151,866
+223% +$2.25M 0.31% 58
2020
Q1
$747K Buy
+68,134
New +$747K 0.09% 63
2018
Q2
Sell
-298,472
Closed -$4.25M 123
2018
Q1
$4.25M Buy
298,472
+50,000
+20% +$711K 0.64% 45
2017
Q4
$2.18M Hold
248,472
0.26% 89
2017
Q3
$2.91M Sell
248,472
-47,838
-16% -$560K 0.41% 59
2017
Q2
$4.14M Buy
296,310
+130,000
+78% +$1.82M 0.7% 35
2017
Q1
$2.28M Hold
166,310
0.45% 59
2016
Q4
$1.19M Hold
166,310
0.3% 75
2016
Q3
$2.52M Buy
+166,310
New +$2.52M 0.41% 57